Financhill
Sell
20

LGHT Quote, Financials, Valuation and Earnings

Last price:
$10.34
Seasonality move :
--
Day range:
$10.36 - $10.39
52-week range:
$9.76 - $10.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
291
Avg. volume:
--
1-year change:
--
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    Langar Global HealthTech ETF has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of --, Langar Global HealthTech ETF has an estimated downside of -- from its current price of $10.39.
  • Price Target Upside
    According to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $10.39.

Fair Value

  • According to the consensus of 0 analysts, Langar Global HealthTech ETF has -- downside to fair value with a price target of -- per share.

LGHT vs. S&P 500

  • Over the past 5 trading days, Langar Global HealthTech ETF has underperformed the S&P 500 by -0.34% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Langar Global HealthTech ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Langar Global HealthTech ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Langar Global HealthTech ETF reported revenues of --.

Earnings Growth

  • Langar Global HealthTech ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Langar Global HealthTech ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-27 2023-12-27 2023-12-27
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2020-12-27 2021-12-27 2022-12-27 2023-12-27
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-27 2023-12-27 2023-12-27
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
LGHT
Sector
Market Cap
--
--
Price % of 52-Week High
96.12%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $10.39
200-day SMA
Sell
Level $10.44
Bollinger Bands (100)
Sell
Level 10.26 - 10.66
Chaikin Money Flow
Sell
Level -36.1K
20-day SMA
Sell
Level $10.54
Relative Strength Index (RSI14)
Sell
Level 45.19
ADX Line
Buy
Level 14.08
Williams %R
Neutral
Level -59.0585
50-day SMA
Sell
Level $10.48
MACD (12, 26)
Sell
Level -0.04
25-day Aroon Oscillator
Sell
Level -24
On Balance Volume
Neutral
Level 24.4K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
--
Momentum Score
Level (--)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Stock Forecast FAQ

In the current month, LGHT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LGHT average analyst price target in the past 3 months is --.

  • Where Will Langar Global HealthTech ETF Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Langar Global HealthTech ETF share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Langar Global HealthTech ETF?

    Analysts are divided on their view about Langar Global HealthTech ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Langar Global HealthTech ETF is a Sell and believe this share price will rise from its current level to --.

  • What Is Langar Global HealthTech ETF's Price Target?

    The price target for Langar Global HealthTech ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is LGHT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Langar Global HealthTech ETF is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of LGHT?

    You can purchase shares of Langar Global HealthTech ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Langar Global HealthTech ETF shares.

  • What Is The Langar Global HealthTech ETF Share Price Today?

    Langar Global HealthTech ETF was last trading at $10.34 per share. This represents the most recent stock quote for Langar Global HealthTech ETF. Yesterday, Langar Global HealthTech ETF closed at $10.39 per share.

  • How To Buy Langar Global HealthTech ETF Stock Online?

    In order to purchase Langar Global HealthTech ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 6.68% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is down 1.14% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 3.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock